AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

Chat with us on WhatsApp

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

CVS Health Explores Potential Split of Retail Pharmacy and Insurance Units

First Detected: Nov 3, 2026, 11:04 PM

Last Update: 2 minutes ago

1 update

Event Summary

CVS Health is exploring a potential separation of its retail pharmacy operations and insurance business into separate entities. The strategic review comes amid investor pressure and operational challenges, according to a Financial Times report.

Timeline

Latest developmentabout 8 hours ago

CVS Plans to Split Its $117 Billion Business Into Two Public Companies

CVS Health will house insurance, pharmacy benefit management and healthcare businesses, while CVS Pharmacy will combine stores, mail-order pharmacy and MinuteClinic clinics.

Read the full story

Key facts

CVS Health is exploring a potential split of its retail pharmacy and insurance businesses into separate entities.
CVS Health is exploring a potential split of its business units, including separating its retail pharmacy operations from its insurance business.
The strategic review comes amid investor pressure and operational challenges, according to a Financial Times report.